Results 111 to 120 of about 5,194 (193)

Hereditary tyrosinaemia type 1 in the absence of succinylacetone: 4‐oxo 6‐hydroxyhepanoate (4OHHA), a putative diagnostic biomarker

open access: yesJIMD Reports
Hereditary tyrosinemia type 1 (HT1) is a rare metabolic disease resulting in acute liver failure in early infancy, hypophosphataemic rickets, neurological crises, liver cirrhosis and risk of hepatocellular carcinoma later on in life.
Preeya Rehsi   +9 more
doaj   +1 more source

Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype. [PDF]

open access: yesGenes (Basel), 2023
Neuckermans J   +13 more
europepmc   +1 more source

Short-term nitisinone discontinuation of hereditary tyrosinemia type 1 mice causes metabolic alterations in glutathione metabolism/biosynthesis and multiple amino acid degradation pathways. [PDF]

open access: yesGenes Dis, 2023
Haaike CV   +13 more
europepmc   +1 more source

Opportunities and costs of clinical research. [PDF]

open access: yes, 1985
Gavaler, JS   +3 more
core   +1 more source

Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway. [PDF]

open access: yesJ Inherit Metab Dis, 2022
van Vliet K   +34 more
europepmc   +1 more source

Pediatric Hepatology: A three-year experience with pediatric liver transplantation with cyclosporine and steroids [PDF]

open access: yes, 1986
Gartner, JC   +6 more
core  

NTBC Treatment Monitoring in Chilean Patients with Tyrosinemia Type 1 and Its Association with Biochemical Parameters and Liver Biomarkers. [PDF]

open access: yesJ Clin Med, 2021
Fuenzalida K   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy